|View printer-friendly version|
|BrainStorm Cell Therapeutics to Participate in Movement Disorder Panel at the Neurotech Investing and Partnering Conference|
Current treatments for movement disorders can improve functioning, but suffer from side effects and "off" period, especially as the disease progresses. A number of novel pipeline pharmaceuticals and devices seek to address these issues. This session will explore how disease modifying treatments alter the course of movement disorders, and how companion diagnostics can be leveraged to provide the most optimal outcomes for patients. The panel will be moderated by
Now in its 13th year, the
Organized by the
This market-defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.
Statements in this announcement other than historical data and information constitute "forward-looking statements" and involve risks and uncertainties that could cause
View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-to-participate-in-movement-disorder-panel-at-the-neurotech-investing-and-partnering-conference-300640050.html